Operating Lease, Right-of-Use Asset of ENDRA Life Sciences Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ENDRA Life Sciences Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • ENDRA Life Sciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $491,363, a 114% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ENDRA Life Sciences Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $491,363 +$261,592 +114% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $519,966 +$247,682 +91% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $546,216 +$232,501 +74% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $578,013 +$223,922 +63% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $229,771 -$163,680 -42% 30 Sep 2024 10-Q/A 21 Nov 2024 2024 Q3
Q2 2024 $272,284 -$159,558 -37% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $313,715 -$155,575 -33% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $354,091 -$151,725 -30% 31 Dec 2023 10-K/A 07 Apr 2025 2024 FY
Q3 2023 $393,451 -$148,005 -27% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $431,842 -$144,413 -25% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $469,290 -$140,944 -23% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $505,816 -$137,597 -21% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $541,456 -$134,366 -20% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $576,255 -$131,249 -19% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $610,234 +$288,671 +90% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $643,413 +$304,401 +90% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $675,822 +$319,762 +90% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $707,504 +$334,784 +90% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $321,563 -$67,441 -17% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $339,012 -$65,907 -16% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $356,060 -$64,428 -15% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $372,720 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $389,004 +$389,004 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $404,919 +$404,919 31 Dec 2019 10-K 25 Mar 2021 2020 FY
Q3 2019 $420,488 +$420,488 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q1 2019 $0 31 Mar 2019 10-Q 14 May 2020 2020 Q1
Q4 2018 $0 31 Dec 2018 10-K 26 Mar 2020 2019 FY
Q3 2018 $0 30 Sep 2018 10-Q 13 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.